← TrialMatch
HomeTrials

Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assess

EUGENIE is a prospective multicentre interventional study, focused on improving endometrial cancer (EC) assessment by combining the new technique of genomic profiling with surgical extra uterine disease assessment. The investigators aim to correlate EC stage to each of the molecular subgroups of disease and thereby gui

Condition(s)Endometrial Cancer
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryEUGENIE is a prospective multicentre interventional study, focused on improving endometrial cancer (EC) assessment by combining the new technique of genomic profiling with surgical extra uterine disease assessment. The investigators aim to correlate EC stage to each of the molecular subgroups of disease and thereby guide surgical treatment and staging of EC by determining the association between molecular classification and disease stage and evaluating if and how disease stage in each of the molecular subgroups associates with prognosis.
Who can participateInclusion Criteria: * Voluntary written informed consent of the participant or their legally authorized representative has been obtained before any screening procedures * Women ≥ 18 years * First diagnosis of EC, all disease stages and all histo-types Exclusion Criteria: * Participant has a history of pelvic or para-aortic lymph node dissection or sampling, previous pelvic (and/or para-aortic) radiotherapy, previous neoadjuvant chemotherapy * Any disorder, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol * Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Study
Ages18 Years
SexFemale
Lead sponsorUniversity Hospital, Gasthuisberg
LocationsLeuven, Belgium
Start date2023-01-16
NCT IDNCT06354738
Official listinghttps://clinicaltrials.gov/study/NCT06354738

🔍 Search all trials →